These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 13553833)

  • 1. [Insulin with prolonged action].
    Policlinico Prat; 1958 Mar; 65(9):345-6. PubMed ID: 13553833
    [No Abstract]   [Full Text] [Related]  

  • 2. Lente insulin, clinical study of a new insulin zinc preparation of prolonged action.
    HOLCOMB B; PAGE OC; STEPHENS JW
    Northwest Med; 1954 Mar; 53(3):239-41. PubMed ID: 13154705
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental determination of the prolonged effects of preparations of clupeine zinc insulin and salmine zinc insulin].
    HERBAIN M
    Ann Pharm Fr; 1954 Feb; 12(2):121-5. PubMed ID: 13171731
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible pegylation of insulin facilitates its prolonged action in vivo.
    Shechter Y; Mironchik M; Rubinraut S; Tsubery H; Sasson K; Marcus Y; Fridkin M
    Eur J Pharm Biopharm; 2008 Sep; 70(1):19-28. PubMed ID: 18495444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of insulin delivery affects hepatic insulin sensitizing substance (HISS) action and insulin resistance.
    Reid MA; Lautt WW
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1068-74. PubMed ID: 15644948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.
    Asplin KE; Sillence MN; Pollitt CC; McGowan CM
    Vet J; 2007 Nov; 174(3):530-5. PubMed ID: 17719811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin.
    Shechter Y; Mironchik M; Rubinraut S; Saul A; Tsubery H; Fridkin M
    Bioconjug Chem; 2005; 16(4):913-20. PubMed ID: 16029032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged glucose requirements after intentional glargine and aspart overdose.
    Fromont I; Benhaim D; Ottomani A; Valéro R; Molines L; Vialettes B
    Diabetes Metab; 2007 Nov; 33(5):390-2. PubMed ID: 17644447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery.
    Kwon JH; Lee BH; Lee JJ; Kim CW
    Eur J Pharm Sci; 2004 Jun; 22(2-3):107-16. PubMed ID: 15158896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin's 85th anniversary--An enduring medical miracle.
    Heller S; Kozlovski P; Kurtzhals P
    Diabetes Res Clin Pract; 2007 Nov; 78(2):149-58. PubMed ID: 17482306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial.
    McSorley PT; Bell PM; Young IS; Atkinson AB; Sheridan B; Fee JP; McCance DR
    Diabet Med; 2005 Jun; 22(6):703-10. PubMed ID: 15910620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central administration of insulin suppresses food intake in chicks.
    Honda K; Kamisoyama H; Saneyasu T; Sugahara K; Hasegawa S
    Neurosci Lett; 2007 Aug; 423(2):153-7. PubMed ID: 17693022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intelligent polymeric systems for glucose-responsive insulin delivery].
    Qu J; Chu L; Li Y; Chen W; Zheng C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):1028-30. PubMed ID: 15646358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes and prolonged fasting.
    Reiter J; Wexler ID; Shehadeh N; Tzur A; Zangen D
    Diabet Med; 2007 Apr; 24(4):436-9. PubMed ID: 17367310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
    Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
    J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
    Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
    Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal insulin improves memory in humans.
    Benedict C; Hallschmid M; Hatke A; Schultes B; Fehm HL; Born J; Kern W
    Psychoneuroendocrinology; 2004 Nov; 29(10):1326-34. PubMed ID: 15288712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged insulin treatment inhibits GH signaling via STAT3 and STAT1.
    Xu J; Ji S; Venable DY; Franklin JL; Messina JL
    J Endocrinol; 2005 Mar; 184(3):481-92. PubMed ID: 15749807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.
    Pfützner A; Forst T
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1097-106. PubMed ID: 16296812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.